Table 1. Relationship between SALL4 expression and clinicopathologic characteristics in endometrial cancer (n = 80).
Parameter | N | Positive (%) | P |
---|---|---|---|
Age | |||
≤50 | 33 | 22 (66.7%) | 0.586 |
>50 | 47 | 34 (72.3%) | |
FIGO stage | |||
I-II | 52 | 30 (57.7%) | 0.001 |
III-IV | 28 | 26 (92.9%) | |
Histological grade | |||
G1 | 38 | 29 (76.3%) | 0.309 |
G2 | 29 | 20 (69.0%) | |
G3 | 13 | 7 (53.9%) | |
Lymph node metastasis | |||
Positive | 26 | 22 (84.6%) | 0.048 |
Negative | 54 | 34 (63.0%) | |
Myometrial invasion | |||
≤1/2 | 45 | 26 (57.8%) | 0.007 |
>1/2 | 35 | 30 (85.7%) |